THERAPEUTIC USES OF BETA-ANTAGONISTS

THERAPEUTIC USES OF BETA-ANTAGONISTS

US20100062980A1

Saved in:

Bibliographic Details
Main Authors:	KINI MANJUNATHA RAMACHANDRA, PUNG YUH FEN, ZHU YI ZHUN, WONG TSUN HON PETER, KUMAR PRAKASH, RAJAGOPALAN NANDHAKISHORE
Other Authors:	BIOLOGICAL SCIENCES
Format:	Patent
Published:	2012
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/34950
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

NOVEL SNAKE TOXIN
by: KINI, MANJUNATHA RAMACHANDRA, et al.
Published: (2012)

Beta-Cardiotoxin: A novel protein isolated from the venom of Ophiophagus hannah (king cobra) showing beta-blocker activity
by: RAJAGOPALAN NANDHAKISHORE
Published: (2011)

THERAPEUTIC MOLECULES
by: GOPALADRISHNAKONE, PONNAMPALAM, et al.
Published: (2012)

Therapeutic molecules derived from snake venom
by: GOPALAKRISHNAKONE, PONNAMPALAM, et al.
Published: (2012)

β-Cardiotoxin: A new three-finger toxin from Ophiophagus hannah (king cobra) venom with beta-blocker activity
by: Rajagopalan, N., et al.
Published: (2011)

β-Cardiotoxin: A new three-finger toxin from Ophiophagus hannah (king cobra) venom with beta-blocker activity
by: Rajagopalan, N., et al.
Published: (2014)

Effects of beta-adrenergic antagonists (carvedilol and propranolol) on beta 2-adrenergic receptors and factor VIII levels in hyperthyroid cats
by: Janpen Bangsumruaj
Published: (2008)

Candoxin, a novel toxin from Bungarus candidus, is a reversible antagonist of muscle (αβγδ) but a poorly reversible antagonist of neuronal α7 nicotinic acetylcholine receptors
by: Nirthanan, S., et al.
Published: (2012)

Ohanin - A novel protein from king cobra (Ophiophagus hannah) venom
by: PUNG YUH FEN
Published: (2010)

Candoxin, a novel toxin from Bungarus candidus, is a reversible antagonist of muscle (αβγδ) but a poorly reversible antagonist of neuronal α7 nicotinic acetylcholine receptors
by: Nirthanan, S., et al.
Published: (2014)

THERAPEUTIC POTENTIAL OF CHIMERIC AMYLOID-BETA PRECURSOR PROTEIN INTRACELLULAR DOMAIN MUTANT IN ALZHEIMER'S DISEASE
by: PAWAN KUMAR
Published: (2020)

Interleukin-6 Antagonists: Lessons From Cytokine Release Syndrome to the Therapeutic Application in Severe COVID-19 Infection
by: Jennis Meanwatthana, et al.
Published: (2022)

Identification Of An Antagonistic Actinomycete And Its Use In The
by: Perpustakaan UGM, i-lib
Published: (1994)

Leukotriene receptor antagonists
by: Van Bever, H.P.S.
Published: (2014)

Role of angiotensin II receptor antagonists in the treatment of hypertension
by: Zhu, Y.Z., et al.
Published: (2012)

Role of angiotensin II receptor antagonists in the treatment of hypertension
by: Zhu, Y.Z., et al.
Published: (2016)

Opioid antagonists for alcohol dependence.
by: Srisurapanont M., et al.
Published: (2014)

Treatment of sarcopenia by antagonists of myostatin
by: Anissa Anindya Widjaja
Published: (2013)

Pharmacoproteomics of cysteinyl leukotriene 1 receptor antagonist in allergic airway inflammation
by: ZHU HUA
Published: (2014)

Mapping of the binding surface between EPHA5 and antagonist peptide by NMR spectroscopy
by: ZHU WANLONG
Published: (2010)

Inhibition of acetylcholinesterase by histamine agonists and antagonists
by: Lee, H.S., et al.
Published: (2012)

Pharmacophoric models of sodium channel antagonists
by: POON THONG YUEN
Published: (2010)

FAIM : an antagonist of Fas-killing and beyond
by: Huo, Jianxin, et al.
Published: (2020)

Design of beta-turn peptides from CD2 protein as therapeutic agents for autoimmune diseases
by: LIU JINING
Published: (2019)

Preface
by: Manjunatha Kini, R.
Published: (2014)

Platelet aggregation and exogenous factors from animal sources
by: Manjunatha Kini, R.
Published: (2014)

Proline brackets and identification of potential functional sites in proteins: Toxins to therapeutics
by: Kini, R.M.
Published: (2014)

The prospects for therapy with tumour necrosis factors and their antagonists
by: Porter, A.G.
Published: (2014)

The current status of calcium antagonists in cardiovascular therapy
by: Chia, B.L., et al.
Published: (2014)

The current status of calcium antagonists in cardiovascular therapy
by: Chia, B.L., et al.
Published: (2016)

Mining Antagonistic Communities From Social Networks
by: ZHANG, Kuan
Published: (2010)

Mining antagonistic communities from social networks
by: ZHANG, Kuan, et al.
Published: (2010)

Ceramides and glucosylceramides are independent antagonists of insulin signaling
by: Chavez, J.A., et al.
Published: (2014)

From snake venom toxins to therapeutics - Cardiovascular examples
by: Koh, C.Y., et al.
Published: (2014)

Cysteinyl leukotriene receptor antagonist MK-571 alters bronchoalveolar lavage fluid proteome in a mouse asthma model
by: Wong, W.S.F., et al.
Published: (2011)

Drysdalin, an antagonist of nicotinic acetylcholine receptors highlights the importance of functional rather than structural conservation of amino acid residues
by: Chandna, R., et al.
Published: (2021)

Screening and characterization of potential small molecule antagonists of myostatin.
by: Lee, Rachel Hui Min.
Published: (2012)

Antagonistic activity of Trichoderma sp. against Bipolaris sp.
by: Mandapat, Joseph B.
Published: (2016)

Mining direct antagonistic communities in signed social networks
by: LO, David, et al.
Published: (2013)

Mining Indirect Antagonistic Communities from Social Interactions
by: ZHANG, Kuan, et al.
Published: (2013)